Showing results (581-590 of 1,286) with videos related to
Sort By:
Pageof 129
Journal of Cardiovascular Pharmacology and Therapeutics|May 10, 2018
Effects of Long- and Intermediate-Acting Dihydropyridine Calcium Channel Blockers in Hypertension: A Systematic Review and Meta-Analysis of 18 Prospective, Randomized, Actively Controlled TrialsSandip Chaugai, Lhamo Yangchen Sherpa, Amir Ali Sepehry, et al.Journal of Cardiovascular Pharmacology and Therapeutics|May 29, 2018
Evaluation of Adherence to Guideline-Directed Antithrombotic Therapy for Atrial Fibrillation at Hospital DischargeLori Dupree, Marci DeLosSantos, Carmen SmothermanJournal of Cardiovascular Pharmacology and Therapeutics|May 18, 2018
Comparison of LDL-C Reduction Using Different Evolocumab Doses and Intervals: Biological Insights and Treatment ImplicationsScott M Wasserman, Marc S Sabatine, Michael J Koren, et al.Journal of Cardiovascular Pharmacology and Therapeutics|June 8, 2017
Metabolic SyndromeDawn Harris Sherling, Parvathi Perumareddi, Charles H HennekensJournal of Cardiovascular Pharmacology and Therapeutics|June 8, 2017
Strategies to Optimize Dual Antiplatelet Therapy After Coronary Artery Stenting in Acute Coronary SyndromeBridget Paravattil, Hazem ElewaJournal of Cardiovascular Pharmacology and Therapeutics|April 27, 2018
Pharmacokinetics/Pharmacodynamics of Dabigatran 75 mg Twice Daily in Patients With Nonvalvular Atrial Fibrillation and Severely Impaired Renal FunctionJack L Martin, Habib Esmaeili, Raymond C Manuel, et al.Journal of Cardiovascular Pharmacology and Therapeutics|May 1, 2018
The Impact of Pazopanib on the Cardiovascular SystemCody N Justice, Mohamed H Derbala, Tesla M Baich, et al.Journal of Cardiovascular Pharmacology and Therapeutics|December 31, 2005
Chlorthalidone improves endothelial-mediated vascular responses in hypertension complicated by nondiabetic metabolic syndromeGiulia Dell'Omo, Giuseppe Penno, Stefano Del Prato, et al.Journal of Cardiovascular Pharmacology and Therapeutics|October 23, 2009
Astaxanthin reduces oxidative stress, but not aortic damage in atherosclerotic rabbitsPaula R Augusti, Greicy M M Conterato, Sabrina Somacal, et al.Journal of Cardiovascular Pharmacology and Therapeutics|August 11, 2018
Utility of the JT Peak Interval and the JT Area in Determining the Proarrhythmic Potential of QT-Shortening AgentsBo Qiu, Yuhong Wang, Congxin Li, et al.Pageof 129